28 Amendments of Colm BURKE
Amendment 9 #
2008/2177(INI)
Motion for a resolution
Paragraph 6
Paragraph 6
6. Calls on the Commission to set up a working party with a binding mandate to carry out within one year a systematic study of the stakeholders' positions and arguments for and against a pan- European cormorant management plancost- benefit analysis of possible cormorant management actions at Member State level, to assess their plausibility on the basis of logical and scientific criteria and to submit a recommendation;
Amendment 11 #
2008/2177(INI)
Motion for a resolution
Paragraph 7
Paragraph 7
7. Calls on the Commission to submit a cormorant population management plan in several stages, seeking to integrate cormorant populations in the long term into the cultural landscape withoudevelop and publish, building on the results of the INTERCAFE project, a guidance document on ways to address the cormorant issue that do not jeopardisinge the objectives of the Wild Birds Directive and Natura 2000 as regards fish species and marine and freshwater ecosystems, including how Article 9(1) of the Wild Birds Directive can be applied by Member States;
Amendment 14 #
2008/2177(INI)
Motion for a resolution
Paragraph 9
Paragraph 9
Amendment 18 #
2008/2177(INI)
Motion for a resolution
Paragraph 11
Paragraph 11
11. Calls on the Commission to consider all the legal means at its disposal to reduce the negative effects of ecormorant populations on fishing and aquaculture and to take into account, when developing its initiative for the promotion of aquaculture in Europe, the positive effects of a Europe-wide cormorant population management plan and, where appropriate, to propose solutions to the cormorant problemnomic and ecological factors affecting fishing and aquaculture when developing its initiative for the promotion of aquaculture in Europe and to propose solutions in this context;
Amendment 49 #
2008/0142(COD)
Proposal for a directive
Recital 8
Recital 8
(8) This directive aims to establish a general framework for provision of safe, high quality and efficient cross-border healthcare in the Community and, to ensure patients mobility and freedom to provide healthcare and high level of protection of health and to facilitate the provision of cross-border healthcare, whilst fully respecting the responsibilities of the Member States for the definition of social security benefits related to health and the organisation and delivery of healthcare and medical care and social security benefits in particular for sickness.
Amendment 71 #
2008/0142(COD)
Proposal for a directive
Recital 8
Recital 8
(8) This directive aims to establish a general framework for provision of safe, high quality and efficient cross-border healthcare in the Community and, to ensure patients mobility and freedom to provide healthcare and high level of protection of health and to facilitate the provision of cross-border healthcare, whilst fully respecting the responsibilities of the Member States for the definition of social security benefits related to health and the organisation and delivery of healthcare and medical care and social security benefits in particular for sickness.
Amendment 100 #
2008/0142(COD)
Proposal for a directive
Recital (40)
Recital (40)
(40) European reference networks should provide healthcare to all patients who have conditions requiring a particular concentration of resources or expertise, in order to provide affordable, high quality and cost-effective care and could also be focal points for medical training and research, information dissemination and evaluation. The mechanism for identification and development of the European reference networks should be established with the aim to organise at European level equal access to high level shared expertise in a given medical field for all patients as well as for health professionals. Significant synergies could be achieved by combining the institutional framework for reference networks with the central contact points within Member States, pursuant to Recital 34.
Amendment 160 #
2008/0142(COD)
Proposal for a directive
Recital 33
Recital 33
(33) Procedures regarding cross-border healthcare established by the Member States should give patients guarantees of objectivity, non-discrimination and transparency, in such a way as to ensure that decisions by national authorities are made in a timely manner and with due care and regard for both those overall principles and the individual circumstances of each case. This applies also to the actual reimbursement of costs of healthcare incurred in another Member State after the patient's return. It is appropriate that pPatients should normally have a decision regarding the cross-border healthcare within fifteen calendar days. However, that period should be shorter where warranted by the urgency of the treatment in question. In any event, recognition procedures and rules on the provision of services as provided for by Directive 2005/36/EC of the European Parliament and of the Council of 7 September 2005 on the recognition of professional qualifications should not be affected by these general rules.
Amendment 174 #
2008/0142(COD)
Proposal for a directive
Article 5 – paragraph 1 – point a
Article 5 – paragraph 1 – point a
(a). mechanisms, which deliver high quality systematic education and training for healthcare professionals, are in place forto ensuringe that healthcare providers are able to meet such standards, taking into account international medical science and generally recognised good medical practices;
Amendment 175 #
2008/0142(COD)
Proposal for a directive
Recital 40
Recital 40
(40) European reference networks should provide healthcare to all patients who have conditions requiring a particular concentration of resources or expertise, in order to provide affordable, high quality and cost-effective care and could also be focal points for medical training and research, information dissemination and evaluation. The mechanism for identification and development of the European reference networks should be established with the aim to organise at European level equal access to high level shared expertise in a given medical field for all patients as well as for health professionals. Significant synergies could be achieved by combining the institutional framework for reference networks with the central contact points within Member States, pursuant to Recital 34.
Amendment 183 #
2008/0142(COD)
Proposal for a directive
Article 5 – paragraph 1 – point c a (new)
Article 5 – paragraph 1 – point c a (new)
(ca) there shall be an EU register of professional medical practitioners who have been struck off the medical register of any Member State in the EU;
Amendment 226 #
2008/0142(COD)
Proposal for a directive – amending act
Article 6 – paragraph 2
Article 6 – paragraph 2
2. The costs of healthcare provided in another Member State shall be reimbursed by the Member State of affiliation in accordance with the provisions of this Directive up to the level of costs that would have been assumed had the same or similar healthcare been provided in the Member State of affiliation, without exceeding the actual costs of healthcare received. Member States shall cover other related costs, such as therapeutic treatment, provided that the total cost does not exceed the amount payable in the Member States of affiliation.
Amendment 240 #
2008/0142(COD)
Proposal for a directive – amending act
Article 6 – paragraph 4
Article 6 – paragraph 4
4. Member States shall have a mechanism for calculation of costs that are to be reimbursed to the insured person by the statutory social security system for healthcare provided in another Member State. This mechanism shall be based on objective, non-discriminatory criteria known in advance and the costs reimbursed according to this mechanism shall be not less than what would have been assumed had the same or similar healthcare been provided in the territory of the Member State of affiliation. These costs shall also include travel, where a situation of undue delay, or unavailability of treatment in the case of rare diseases, arises, without prejudice to the case of treatments which are specifically proscribed in the Member State of affiliation
Amendment 295 #
2008/0142(COD)
Proposal for a directive
Article 8 – paragraph 5 a – (new)
Article 8 – paragraph 5 a – (new)
5a. Patients who are on a waiting list for medical treatment in their Member State of affiliation shall not be subject to prior authorisation, if the time required to obtain it would be prejudicial to their state of health or their receipt of medical treatment, or where the treatment in question can not be provided for the person concerned in their Member State of affiliation, notwithstanding procedures which are specifically proscribed under the law of the Member State of affiliation.
Amendment 312 #
2008/0142(COD)
Proposal for a directive – amending act
Article 9 – paragraph 3 a (new)
Article 9 – paragraph 3 a (new)
3a. Where prior authorisation has been granted, the Member State of affiliation shall seek reimbursement for any further cost to be provided directly from the purchaser to the provider.
Amendment 318 #
2008/0142(COD)
Proposal for a directive – amending act
Article 9 – paragraph 5 a (new)
Article 9 – paragraph 5 a (new)
5a. The Commission shall conduct a feasibility study into the establishment of a clearing house to facilitate the reimbursement of costs under this Directive across borders, healthcare systems and currency zones within two years of the entry into force of this Directive and shall report back to the European Parliament and the Council and, if appropriate, present a legislative proposal.
Amendment 337 #
2008/0142(COD)
Proposal for a directive
Article 12 – paragraph 2
Article 12 – paragraph 2
2. The national contact point in the Member State of affiliation shall, in close cooperation with other competent national authorities, yet independently of same, and with national contact points in other Member States, in particular in the Member State of treatment, and with the Commission:
Amendment 345 #
2008/0142(COD)
Proposal for a directive
Article 12 – paragraph 2 – point e a (new)
Article 12 – paragraph 2 – point e a (new)
(ea) Primary care providers shall inform patients of the availability and function of the national contact points in their Member State of affiliation.
Amendment 386 #
2008/0142(COD)
Proposal for a directive
Article 16 a (new)
Article 16 a (new)
Article 16a Telemedicine Telemedicine practitioners who provide healthcare for patients in the EU shall be registered with the medical regulator of the Member State from where the telemedicine treatment is provided.
Amendment 405 #
2008/0142(COD)
Proposal for a directive
Article 6 – paragraph 2
Article 6 – paragraph 2
2. The costs of healthcare provided in another Member State shall be reimbursed by the Member State of affiliation in accordance with the provisions of this Directive up to the level of costs that would have been assumed had the same or similar healthcare been provided in the Member State of affiliation, without exceeding the actual costs of healthcare received. Member States shall cover other related costs, such as therapeutic treatment, provided that the total cost does not exceed the amount payable in the Member States of affiliation.
Amendment 451 #
2008/0142(COD)
Proposal for a directive
Article 8 – paragraph 1
Article 8 – paragraph 1
1. For the purposes of reimbursement of healthcare provided in another Member State in accordance with this Directive, the definition of hospital care shall mean: (a)be limited to: - healthcare which requires overnight accommodation of the patient in question for at least one night. (b) healthcare, included in a specific list, that does not require overnight accommodation of the patient for at least one night. This list shall be limited to: -, or healthcare that requires use of highly specialised and cost- intensive medical infrastructure or medical equipment; or - healthcare involving treatments presenting a particular risk for the patient or the population.
Amendment 514 #
2008/0142(COD)
Proposal for a directive
Article 9 – paragraph 2
Article 9 – paragraph 2
2. Any such procedural systems shall be easily accessible and capable of ensuring that requests are dealt with objectively and impartially within a time limits set out and made public in advance by the Member State which should not exceed fifteen calendar days.
Amendment 666 #
2008/0142(COD)
Article 15 - paragraph 3 - point a - subpoint ix a (new)
(ixa) investigate the possibility of combining national contact points and European reference networks in a single institutional structure in each respective Member State.
Amendment 245 #
2008/0018(COD)
Proposal for a directive
Article 52
Article 52
Member States shall not impede the placing on the market of toys which are in accordance with Directive 88/378/EEC and which weare placed on the market before this Directive entered into for[2 years after the entry into force of this Directive]. Annex II, Part III shall only apply to toys placed or at the latest 2n the market after [5 years after this Directive enteredry into force. of this Directive/31 May 2013]
Amendment 251 #
2008/0018(COD)
Proposal for a directive
Annex I – point 17 a (new)
Annex I – point 17 a (new)
17a. Books that do not contain any elements or added objects others than those in paper or cardboard.
Amendment 320 #
2008/0018(COD)
Proposal for a directive
Annex II – Part III – point 4 a (new)
Annex II – Part III – point 4 a (new)
4a. Manufacturers may continue placing toys on the market containing the substances classified as CMRs according to Annex I of Directive 67/548/EEC for which a request has been submitted to the relevant scientific committee in accordance with Paragraph 4.1 until a Decision as referred to in Article 45(2) has been taken.
Amendment 339 #
2008/0018(COD)
Proposal for a directive
Annex II – Part III – point 7
Annex II – Part III – point 7
7. Toys shall not contain the following allergenic fragrances: (1) Alanroot (Inula helenium) (2) Allylisothiocyanate (3) Benzyl cyanide (4) 4 tert-Butylphenol (5) Chenopodium oil (6) Cyclamen alcohol (7) Diethyl maleate (8) Dihydrocoumarin (9) 2,4-Dihydroxy-3-methylbenzaldehyde (10) 3,7-Dimethyl-2-octen-1-ol (6,7- Dihydrogeraniol) (11) 4,6-Dimethyl-8-tert-butylcoumarin (12) Dimethyl citraconate (13) 7,11-Dimethyl-4,6,10-dodecatrien-3- one (14) 6,10-Dimethyl-3,5,9-undecatrien-2- one (15) Diphenylamine (16) Ethyl acrylate (17) Fig leaf, fresh and preparations (18) trans-2-Heptenal (19) trans-2-Hexenal diethyl acetal (20) trans-2-Hexenal dimethyl acetal (21) Hydroabietyl alcohol (22) 4-Ethoxy-phenol (23) 6-lsopropyl-2-decahydronaphthalenol (24) 7-Methoxycoumarin (25) 4-Methoxyphenol (26) 4-(p-Methoxyphenyl)-3-butene-2-one (27) 1-(p-Methoxyphenyl)-1-penten-3-one (28) Methyl trans-2-butenoate (29) 6-Methylcoumarin (30) 7-Methylcoumarin (31) 5-Methyl-2,3-hexanedione (32) Costus root oil (Saussurea lappa Clarke) (33) 7-Ethoxy-4-methylcoumarin (34) Hexahydrocoumarin (35) Peru balsam (Myroxylonpereirae Klotzsch) (36) 2-Pentylidene-cyclohexanone (37) 3,6,10-Trimethyl-3,5,9-undecatrien-2- one (38) Verbana oil (Lippia citriodora Kunth). (39) Musk ambrette (40) 4-Phenyl-3-buten-2-one (41) Amyl cinnamal (42) Amylcinnamyl alcohol (43) Benzyl alcohol (44) Benzyl salicylate (45) Cinnamyl alcohol (46) Cinnamal (47) Citral (48) Coumarin (49) Eugenol (50) Geraniol (51) Hydroxycitronellal (52) Hydroxymethylpentylcyclohe xenecarboxaldehyde (53) Isoeugenol However, the presence of traces of these substances shall be allowed provided that such presence is technically unavoidable in good manufacturing practice. In addition the following allergenic fragrances shall be listed if added to toys, as such, at concentrations exceeding 0,01 % by weight: (1) Amyl cinnamal (2) Amylcinnamyl alcohol (3) Anisyl alcohol (4) Benzyl alcohol (5nisyl alcohol (2) Benzyl benzoate (63) Benzyl cinnamate (7) Benzyl salicylate (8) Cinnamal (9) Cinnamyl alcohol (10) Citral (11) Citronellol (12) Coumarin (13) Eugenol (14) Farnesol (15) Geraniol (14) Citronellol (5) Farnesol (6) Hexyl cinnamaldehyde (17) Hydroxy-citronellal (18) Hydroxy- methylpentylcyclohexenecarboxaldehyde (19) Isoeugenol (20) Lilial (referred to in the Cosmetics Directive in entry 83 as: 2-(4-tert- Butylbenzyl) propionaldehyde (21Lilial (8) d-Limonene (229) Linalool (2310) Methyl heptine carbonate (24) 11)3-methyl-4-(2,6,6-trimethyl-2- cyclohexen-1-yl)-3-buten-2-one (125) Oakmoss extracts (2613) Treemoss extracts
Amendment 370 #
2008/0018(COD)
Proposal for a directive
Annex V - Part B - Point 7
Annex V - Part B - Point 7
Toys contained in food or co-mingled with food shall contain the warning: “Adult supervision strongly recommended”.